06.07.2011 • NewsChinaEvonikHPPO

Evonik-Uhde Process Basis of Propylene Oxide Plant Contract in China

Representatives of Uhde, Evonik and a delegation from the Chinese province of Jilin have signed a non-exclusive license for the construction and operation of an HPPO (hydrogen peroxide propylene oxide) plant at Jilin in north-east China. Uhde's scope of services will include key parts of the engineering design, supply of equipment and plant erection and commissioning support.

The licensing agreement will allow a joint venture which to be formed between Jilin Shenhua and Jilin North Chemical Company (JNCC) to build a plant for the production of 300,000 tons of propylene oxide based on a process developed by Uhde and Evonik. Propylene oxide is a raw material for polyurethane foams, which are used for insulation in the building industry, for upholstering comfortable furniture and for automotive lightweight construction.

The advantages of the HPPO process lie in the much lower investment volume, which therefore makes the process more cost-effective than conventional propylene oxide production processes. The HPPO process is also extremely environment-friendly: it has a high yield and apart from water only negligible amounts of by-products are produced. The world's first HPPO plant came on-stream in Ulsan, South Korea, in 2008.

 

Company

ThyssenKrupp Uhde

Friedrich-Uhde-Straße 15
44141 Dortmund
Germany

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.